Apolipoprotein B and Low-Density Lipoprotein Cholesterol are Associated with Left Atrial Enlargement in Patients with Nonvalvular Atrial Fibrillation
page 113~117
DOI: 10.6890/IJGE.202404_18(2).0010
Early Signs of Cardiovascular Senescence in a Patient with Hereditary Hemorrhagic Telangiectasia
page 141~143
DOI: 10.6890/IJGE.202304_17(2).0012
Effectiveness and Safety of Oral Anticoagulants in Patients with Atrial Fibrillation
page 1
DOI: 10.6890/IJGE.202301_17(1).EC
Atrial Fibrillation Known Prior to Stroke and Preceding Oral Anticoagulant Therapy
page 9~12
DOI: 10.6890/IJGE.202301_17(1).0002
Adverse Outcomes Associated with Frailty among Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation
page 322~327
DOI: 10.6890/IJGE.202210_16(4).0002
Factors Predicting Stroke Recurrence in Stroke Patients with Atrial Fibrillation
page 343~347
DOI: 10.6890/IJGE.202210_16(4).0006
Cardiac Tamponade Caused by Atrial Lead Perforation or by Spontaneous Hemopericardium in an Edoxaban User
page 66~68
DOI: 10.6890/IJGE.202201_16(1).0014
Using Glasgow Coma Scale to Identify Acute Large-Vessel Occlusion Stroke
page 64~66
DOI: 10.6890/IJGE.202101_15(1).0013